Chief Medical Officer & Laboratory Director, Renalytix
Professor of Experimental Pathology & Director of Biorepository and Pathology at the Icahn School of Medicine at Mount Sinai, NYC

  • Responsible for overseeing the daily clinical laboratory operations and ensuring all patients receive the highest-quality medical care
  • Board certified, anatomic, clinical and pediatric pathology
  • 20-years of experience in the biotechnology industry in various senior management roles, including at Millenium Pharmaceuticals and Incyte Pharmaceuticals
  • Chief Medical Officer at various life sciences companies: PreciseDx, VericiDx, Aureon Biosciences, MetaStat Inc., Exosome Diagnostics, Inc, Vigilant Biosciences
  • Spearheaded the utilization of multiple tissue and fluid-based assays and coupled mathematical applications to produce clinically relevant diagnostic/prognostic outcome models for a variety of disease states
  • Extensive experience in designing/implementing clinical studies for various disease states
  • Academic Career: Harvard Medical School and Boston Children’s Professor of Pathology at Icahn School of Medicine, Mount Sinai NYC
  • Education:
    • BS, Zoology: Rutgers University
    • MD: University of Medicine & Dentistry of New Jersey
    • Master of Science, Endocrinology: Rutgers University
    • PhD, Cell & Developmental Biology: Rutgers University
    • Post-Doctoral studies: Harvard Medical School